SMTL ID : 3vgx.1

Structure of gp41 T21/Cp621-652

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.74 Å

Oligo State

hetero-3-3-mer

Ligands

3 x ACY: ACETIC ACID(Non-functional Binders)

ACY.1: 2 residues within 4Å: Chain A: R.34, K.37 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:R.34, A:K.37 ACY.3: 2 residues within 4Å: Chain C: R.34, K.37 2 PLIP interactions: 2 interactions with chain C Salt bridges: C:R.34, C:K.37 ACY.5: 2 residues within 4Å: Chain E: R.34, K.37 2 PLIP interactions: 2 interactions with chain E Salt bridges: E:R.34, E:K.37

3 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 5 residues within 4Å: Chain A: E.33, L.36 Chain C: A.31, V.32, Y.35 No protein-ligand interaction detected (PLIP) GOL.4: 5 residues within 4Å: Chain C: E.33, L.36 Chain E: A.31, V.32, Y.35 No protein-ligand interaction detected (PLIP) GOL.6: 5 residues within 4Å: Chain A: A.31, V.32, Y.35 Chain E: E.33, L.36 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chong, H. et al., Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652. J.Biol.Chem. (2012)

Release Date

2012-04-25

Peptides

Envelope glycoprotein gp160: ACE
Envelope glycoprotein gp160: BDF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

C
C

E
C

B
D

D
D

F
D

Envelope glycoprotein gp160

Envelope glycoprotein gp160

Related Entries With Identical Sequence